# Evommune, Inc. (EVMN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EVMN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -53.92M | $ -48.09M | $ 8.11M | $ 277.59M |
| 2025 | $ 13.31M | $ -70.52M | $ -78.51M | $ 2.06M | $ 205.57M |
| 2024 | $ 7.36M | $ -50.96M | $ -33.69M | $ 1.02M | $ 47.54M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 11.68 |

## Other views

- [Metrics](https://sponda.capital/en/EVMN.md)
- [Charts](https://sponda.capital/en/EVMN/charts.md)
- [Compare](https://sponda.capital/en/EVMN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.